AGIO CIK: 1439222

Agios Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
billions USD
FY21:
0
FY22:
0.01
FY23:
0.02
FY24:
0.03
FY25:
0.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.38
FY22:
−0.39
FY23:
−0.39
FY24:
−0.43
FY25:
−0.47
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.38
FY22:
−0.52
FY23:
−0.38
FY24:
−1.51
FY25:
−0.47
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.36
FY22:
−0.23
FY23:
−0.35
FY24:
0.72
FY25:
−0.41
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.60
FY22:
−0.23
FY23:
−0.35
FY24:
0.67
FY25:
−0.41

All amounts in billions USD Data sources:SEC EDGARTwelve Data